The Director-General of the National Institute for Pharmaceutical Research and Development, NIPRD, Dr Obi Adigwe, has said that the federal government is now taking concrete steps to develop and commercialise phytomedicines in Nigeria.
Adigwe said this in an interview with the News Agency of Nigeria, NAN, on Sunday in Abuja, describing the current administration’s efforts as a clear departure from years of neglect and lip service.
According to him, the government had demonstrated seriousness by setting up a ministerial committee on the development and commercialisation of phytomedicines, with NIPRD appointed to lead the process.
Phytomedicines, also known as herbal or botanical medicines, are plant-based products used in the treatment and prevention of diseases.
While rooted in traditional practices, they are increasingly validated through scientific research to ensure their efficacy and safety.
Adigwe highlighted that an estimated 70 to 75 per cent of Nigerians relied on phytomedicines such as ‘agbo, magani, and ogwu igbo’ when ill.
He said in spite of the widespread usage, the sector had previously received inadequate institutional support.
“For a long time, phytomedicines only got lip service, but this administration is taking bold, concrete steps.
“I must commend the Ministers of Health for driving this vision,” he said.
The DG pointed to NIPRD’s track record, including the development of a sickle cell remedy from indigenous plants.
He also highlighted the institute’s leadership during the COVID-19 pandemic, when it conducted the world’s first scientific analysis of the controversial COVID organics herbal preparation.
“That particular product put Nigeria on the map in terms of science and ensured that millions of dollars were not wasted on a product without scientific backing,” Adigwe said.
